Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- ‘What’s normal has changed’: Navigating menopausal hormone therapy as CVD risk grows Regina Schaffer
-
- After many failed trials, novel therapeutics may finally tackle high triglycerides Regina Schaffer
- Baseline glucose, increasing BMI predict progression to type 2 diabetes for children Michael Monostra
- Bone density decreases when stopping, never using menopausal hormone therapy Erin T. Welsh, MA
- Bone density rebounds for transgender people during gender-confirming hormone therapy Michael Monostra
- Dual GLP-1/GIP agonist shows promising impact on liver fat, lipids on top of weight loss Katie Kalvaitis; Michael Monostra
- FDA warns people with diabetes to avoid product sold for blood glucose management
- Intermittent therapy may be a ‘practical strategy’ for maintaining weight loss Michael Monostra
- Is menopausal hormone therapy linked with dementia risk? Studies offer conflicting views Regina Schaffer
-
- Metformin provides glycemic, neonatal benefits for women with gestational diabetes Michael Monostra
- Prioritize, optimize sleep to reap cardiometabolic benefits Regina Schaffer
- Q&A: How to address eating disorders in type 1 diabetes Susan Weiner, MS, RDN, CDN, CDCES, FADCES; Erin Phillips, MPH, RD, CDCES
- Review: Menopause apps need osteoporosis content, expert insight and simplicity Erin T. Welsh, MA
- Teplizumab preserves beta-cell function for children with new-onset type 1 diabetes Michael Monostra
- Tirzepatide earns FDA approval for obesity treatment Michael Monostra; Regina Schaffer
- VIDEO: Many options for anti-obesity medications in the pipeline Michael Monostra; Ania M. Jastreboff, MD, PhD
- VIDEO: Resources for measuring sex, gender identity and sexual orientation in practice Michael Monostra; Marshall Chin, MD, MPH
-
- Weight loss varies with investigational triple agonist for adults with obesity Michael Monostra
- With little evidence, CGM benefits for people without diabetes ‘largely hypothetical’ Regina Schaffer